Catalyst Wire Dossier Catalyst Wire Dossier

Q203

· Qurient Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Q203, covering 2016-12-06 to 2018-05-14. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers [Phase 1]

See pricing